Development and internal validation of a prediction tool to aid the diagnosis of Cushing's syndrome in dogs attending primary-care practice
- PMID: 32935905
- PMCID: PMC7694798
- DOI: 10.1111/jvim.15851
Development and internal validation of a prediction tool to aid the diagnosis of Cushing's syndrome in dogs attending primary-care practice
Abstract
Background: Novel methods to aid identification of dogs with spontaneous Cushing's syndrome are warranted to optimize case selection for diagnostics, avoid unnecessary testing, and ultimately aid decision-making for veterinarians.
Hypothesis/objectives: To develop and internally validate a prediction tool for dogs receiving a diagnosis of Cushing's syndrome using primary-care electronic health records.
Animals: Three hundred and ninety-eight dogs diagnosed with Cushing's syndrome and 541 noncase dogs, tested for but not diagnosed with Cushing's syndrome, from a cohort of 905 544 dogs attending VetCompass participating practices.
Methods: A cross-sectional study design was performed. A prediction model was developed using multivariable binary logistic regression taking the demography, presenting clinical signs and some routine laboratory results into consideration. Predictive performance of each model was assessed and internally validated through bootstrap resampling. A novel clinical prediction tool was developed from the final model.
Results: The final model included predictor variables sex, age, breed, polydipsia, vomiting, potbelly/hepatomegaly, alopecia, pruritus, alkaline phosphatase, and urine specific gravity. The model demonstrated good discrimination (area under the receiver operating curve [AUROC] = 0.78 [95% CI = 0.75-0.81]; optimism-adjusted AUROC = 0.76) and calibration (C-slope = 0.86). A tool was developed from the model which calculates the predicted likelihood of a dog having Cushing's syndrome from 0% (score = -13) to 96% (score = 10).
Conclusions and clinical importance: A tool to predict a diagnosis of Cushing's syndrome at the point of first suspicion in dogs was developed, with good predictive performance. This tool can be used in practice to support decision-making and increase confidence in diagnosis.
Keywords: VetCompass; canine; diagnosis; electronic patient record; endocrinology; hyperadrenocorticism.
© 2020 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine.
Conflict of interest statement
I. S. is supported at the RVC by an award from Dechra Veterinary Products Ltd. S. J. M. N. has undertaken consultancy work for Dechra Veterinary Products Ltd. The remaining authors have no conflicts of interest to declare.
Figures
References
-
- O'Neill DG, Scudder C, Faire JM, et al. Epidemiology of hyperadrenocorticism among 210,824 dogs attending primary‐care veterinary practices in the UK from 2009 to 2014. J Small Anim Pract. 2016;57:365‐373. - PubMed
-
- Helm JR, McLauchlan G, Boden LA, et al. A comparison of factors that influence survival in dogs with adrenal‐dependent hyperadrenocorticism treated with mitotane or trilostane. J Vet Intern Med. 2011;25:251‐260. - PubMed
-
- Fracassi F, Corradini S, Floriano D, et al. Prognostic factors for survival in dogs with pituitary‐dependent hypercortisolism treated with trilostane. Vet Rec. 2015;176:49. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical